关于我们
设想&理念
科学
研究
我们的专业技术
工业许可证
专利
道德
管理&员工
管理
咨询委员会
职业机会
地点
顾问委员会
"成体干细胞-由于我们可以十分容易地从皮肤获取大量干细胞-这为再生医学开辟了新的领域,在未来也将毫无疑问地引领更有效地治疗应用。"
哈佛医学院的助理教授
Markus Frank M.D
博士担任TICEBA的科学顾问。 他目前参与了大量基础研究调查,是美国马萨诸塞州剑桥城哈佛大学医学院的成员。Frank博士为我们的事业带来了干细胞研究领域丰富的知识和专家意见。
受聘专家
Instructor in Medicine, Harvard Medical School, Boston, MA
Principal Investigator
职位和工作内容
Hospital or Affiliated Institution Appointments:
Staff Physician, Department of Medicine, V.A. Medical Center, West Roxbury,
Boston, MA
Associate Physician, Renal Division, Brigham and Women's Hospital,
Boston, MA
Research Associate, Division of Nephrology, Children's Hospital, Boston, MA
Staff Physician, Department of Medicine, Faulkner Hospital, Boston, MA
Consulting Staff, Department of Medical Oncology, Dana Farber Cancer
Institute, Boston, MA
Member, Cutaneous Oncology and Melanoma Program, Dana-Farber/Harvard
Cancer Center, Boston, MA
Hospital & Health Care Organization Clinical Service Responsibilities:
Attending Physician in Medicine/Emergency Medicine, V.A. Medical Center,
West Roxbury
Attending Physician in Nephrology, Brigham and Women's Hospital
Attending Physician in Nephrology, Faulkner Hospital
委员会主要工作
Abstract Review Committee, Member, American Society of Transplantation
Abstract Review Committee, Member, American Society of Nephrology
Scientific Review Committee, Member, Israel Science Foundation
The Stem Cell Program, Member, Children's Hospital
Harvard Stem Cell Institute, Member, Harvard University
AST Cellular Transplantation Committee, Member, American Society of
Transplantation
专业学会
American College of Physicians, Member
American Medical Association, Member
American Society of Transplantation, Member; Member Abstract Review
Committee 2002-2006, Scientific Session Co-Chair 2002-2006
National Kidney Foundation, Member
The Transplantation Society, Member
International Society of Comparative Oncology, Member
American Society of Biochemistry and Molecular Biology, Member
American Society of Human Genetics, Member
American Society for Cell Biology, Member
编委会
Ad-Hoc Reviewer, Journal of the American Society of Nephrology
Ad-Hoc Reviewer, Blood
Ad-Hoc Reviewer, Kidney International
Ad-Hoc Reviewer, Journal of Immunology
Ad-Hoc Reviewer, Molecular BioSystems (Royal Society of Chemistry,
Cambridge, UK)
Ad-Hoc Reviewer, American Journal of Physiology - Cell Physiology
Ad-Hoc Reviewer, Journal of Leukocyte Biology
参考书目
Original Articles:
Frank MH, Pomer S. Interferon alpha2b differentially affects proliferation of
two human renal cell carcinoma cell lines differing in the P-glycoprotein-
associated multidrug-resistant phenotype. J Cancer Res Clin Oncol. 1999;
125(2):117-20.
Frank MH, Denton MD, Alexander SI, Khoury SJ, Sayegh MH, Briscoe DM.
Specific MDR1 Pglycoprotein blockade inhibits human alloimmune T cell
activation in vitro. J Immunol. 2001;166 (4):2451-9.
Frank NY, Pendse SS, Lapchak PH, Margaryan A, Shlain D, Doeing C, Sayegh
MH, Frank MH. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein,
a novel human ATP-binding cassette transporter. J Biol Chem. 2003;
278(47):47156-65.
Lapchak PH, Melter M, Pal S, Flaxenburg JA, Geehan C, Frank MH,
Mukhopadhyay D, Briscoe DM. CD40-induced transcriptional activation
of vascular endothelial growth factor involves a 68- bp region of the
promoter containing a CpG island. Am J Physiol Renal Physiol. 2004;
287(3):F512-20.
Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M,
Sayegh MH, Sadee W, Frank MH. ABCB5-mediated doxorubicin transport and
chemoresistance in human malignant melanoma. Cancer Res. 2005;
65(10):4320-33.
Lutz NW, Franks SE, Frank MH, Pomer S, Hull WE. Investigation of multidrug
resistance in cultured human renal cell carcinoma cells by 31P-NMR
spectroscopy and treatment survival assays. MAGMA. 2005;18(3):144-61.
Frank NY, Kho AT, Schatton T, Murphy GF, Molloy MJ, Zhan Q, Ramoni MF,
Frank MH, Kohane IS, Gussoni E. Regulation of myogenic progenitor
proliferation in human fetal skeletal muscle by BMP4 and its
antagonist Gremlin. J Cell Biol. 2006 Oct 9; 175(1):99-110.
Pendse SS, Behjati S, Schatton T, Izawa A, Sayegh MH, Frank MH.
P-Glycoprotein Functions as a Differentiation Switch in Antigen Presenting
Cell Maturation. Am J Transplant. 2006 Nov 3.
Reviews/Chapters/Editorials:
Pendse S, Briscoe DM, Frank MH. P-glycoprotein and alloimmune T cell
activation. Clinical and Applied Immunology Reviews. 2003;4(1):3-14.
Pendse S, Sayegh MH, Frank MH. P-glycoprotein - a novel therapeutic target
for immunomodulation in clinical transplantation and autoimmunity? Curr Drug
Targets. 2003;4(6):469-76.
Frank MH, Sayegh MH. Immunomodulatory functions of mesenchymal stem
cells. Lancet. 2004;363(9419):1411-2.
Books, Monographs, and Textbooks:
Frank MH, Sayegh MH. Transplantation Tolerance. In: Transplantation 1999:
Progress on the Cusp of the Millennium. New York (NY): Lippincott Williams &
Wilkins Healthcare;1999.
Frank MH, Sayegh MH. Immunology and Tolerance. In: Transplantation 2000:
Transplantation at the Millennium. New York (NY): Lippincott Williams & Wilkins
Healthcare;2000.
Frank MH, Sayegh MH. Tolerance: is it time to move to the clinic? In: Current
and Future Immunosuppressive Therapies Following Transplantation.
Dordrecht, The Netherlands: Kluwer Academic Publishers;2001. p. 293-313.
(Mohamed Sayegh and Giuseppe Remuzzi, editors.)
Frank MH, Sayegh MH. Immunology and Tolerance. In: Transplantation 2001.
New York (NY): Lippincott Williams & Wilkins Healthcare;2001.
Frank MH. Briscoe DM. Monoclonal Antibody Targeting of Adhesion Molecules.
In: Current and Future Immunosuppressive Therapies Following
Transplantation. Dordrecht, The Netherlands: Kluwer Academic Publishers;
2001. p. 249-263. (Mohamed Sayegh and Giuseppe Remuzzi, editors.)
Abstracts:
Frank MH, Shedd SF, Lutz NW, Pomer S, Hull WE. 31P Nuclear Magnetic
Resonance Spectroscopy Study of Multidrug Resistance in Human Renal Cell
Carcinoma. Society of Magnetic Resonance in Medicine 12th Annual
Conference New York, NY. 1993:1015.
Shedd SF, Lutz NW, Frank MH, Hull WE. Choline- and Ethanolamine-
Dependent Regulation of Phosphomonoester and Uridine diphospho-hexose
Metabolism in a Human Colon Cancer Cell Line. Society of Magnetic
Resonance in Medicine 12th Annual Conference New York, NY. 1993:262.
Lu R, Frank M, Schuster VL. Genomic Cloning of the Human Prostaglandin
(PG) Transporter "PGT" Gene. Journal of the American Society of Nephrology.
1996;7:A1997.
Frank MH, Pomer S. IFN-alpha differentially affects proliferation of two renal
cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug
resistance phenotype. UICC 17th International Cancer Congress August 23-28
1998, Rio de Janeiro - Brazil. 1998:A1143.
Frank MH, Denton MD, Alexander SI, Khoury SJ, Sayegh MH, Briscoe DM.
P-glycoprotein is functional in antigen- and alloantigen-dependent T cell
activation. Journal of the American Society of Nephrology. 1999;10:A3551.
Denton MD, Frank MH, Waaga AM, Geehan C, Sayegh MH, Briscoe DM. Human
endothelial cells facilitate indirect allorecognition. Journal of the American
Society of Nephrology. 1999;10:A3540.
Frank MH, Denton MD, Khoury SJ, Briscoe DM, Sayegh MH. Modulators of
P-glycoproteinmediated transmembrane transport inhibit T-cell proliferation
in vitro. Transplantation. 1999;67 (S63):A225.
Frank MH, Denton MD, Alexander SI, Khoury SJ, Sayegh MH, Briscoe DM.
P-glycoprotein blockade inhibits alloimmune T cell activation in vitro. XVIII
International Congress of the Transplantation Society, Rome, Italy, 2000.
2000:p161: Abstract POO26W.
Frank MH, Chitnis T, Abdallah KA, Sayegh MH, Khoury SJ. Tamoxifen inhibits
disease expression in murine experimental autoimmune encephalomyelitis.
Neurology. 2000;54(7 Suppl 3):A61.
Frank MH, Sayegh MH, Briscoe DM. P-glycoprotein function in human
alloimmune interactions. Pediatric Transplantation. 2000;4 (Supplement
No. 2):108: Abstract 0178.
Frank MH, Sayegh MH, Briscoe DM. P-glycoprotein function in alloimmune
lymphocyte/endothelial cell interactions. Journal of the American Society
of Nephrology. 2000;11:661A: A3485.
Frank MH, Sayegh MH, Briscoe DM. P-glycoprotein function in human
alloimmune interactions. Transplantation. 2000;69(8):A78.
Frank MH, Sayegh MH, Briscoe DM. P-glycoprotein blockade inhibits
alloimmune T cell responses via both CD4+ T cell- and CD14+
APC-dependent activation pathways. American Journal of Transplantation.
2001;1(Supplement 1):267: Abstract# 527.
Pendse S, Sayegh, MH, Frank MH. A critical role for P-glycoprotein in early
cytokine-dependent dendritic cell maturation. American Journal of
Transplantation 2002. 2002;2(Supplement 3):265: Abstract# 504.
Pendse S, Sayegh, MH, Frank MH. MDR1 P-glycoprotein blockade inhibits early
cytokinedependent dendritic cell differentiation. Journal of the American
Society of Nephrology. 2002;13:53A.
Izawa A, Frank NY, Pendse S, Sayegh MH, Frank MH. P-glycoprotein blockade
prolongs murine cardiac allograft survival. Circulation. 2003;108(17):IV-331
Abstract 1554.
Frank NY, Pendse S, Lapchak PH, Doeing C, Sayegh MH, Frank MH. Regulation
of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding
cassette transporter. American Journal of Human Genetics. 2003;73
(5 Supplement):327 Abstract 921.
Izawa A, Pendse S, Sayegh MH, Frank MH. MDR1 Specific pharmacologic
P-glycoprotein blockade prolongs murine cardiac allograft survival. American
Journal of Transplantation. 2003;3(Supplement 5):447: Abstract# 1153.
Pendse S, Behjati S, Sayegh MH, Frank MH. MDR1 P-glycoprotein is a dendritic
cell/macrophage differentiation switch in antigen presenting cell maturation.
American Journal of Transplantation. 2003;3(Supplement 5):340:
Abstract# 732.
Frank N, Frank MH, Gussoni E. ABCB5 P-glycoprotein is a molecular marker of
the Hoechst 33342 side population phenotype among human fetal skeletal
muscle cells. The FASEB Journal. 2004;18(4):A183: Abstract 144.9.
Margaryan A, Pütz P, Sayegh MH, Frank MH. Skin-derived ABCB5+
progenitors can be induced to generate insulin-secreting cells in vitro.
The Cell Transplant Society 7th International Congress, Boston, USA,
November 17-20, 2004. 2004;18:Abstract 124.
Margaryan A, Sayegh MH, Frank MH. In vitro generation of insulin-secreting
cells from adult skin-derived ABCB5+ progenitors. Journal of the American
Society of Nephrology. 2004;15:647A.
Izawa A, Frank NY, Pendse SS, Margaryan A, Sho M, Sayegh MH, Frank MH.
In vivo regulation of Th1 responses and murine cardiac allograft rejection by
multidrug resistance Pglycoprotein. American Journal of Transplantation.
2004;4(Supplement 8):412: Abstract# 931.
Frank NY, Margaryan A, Huang Y, Waaga-Gasser AM, Gasser M, Sayegh MH,
Sadee W, Frank MH. ABCB5-mediated doxorubicin transport and
chemoresistance in human malignant melanoma. Proceedings of the American
Association for Cancer Research. 2005;46:554 Abstract #2362.
Frank NY, Margaryan A, Huang Y, Schatton T, Waaga-Gasser AM, Gasser M,
Sayegh MH, Sadee W, Frank MH. ABCB5-mediated chemoresistance in human
malignant melanoma. 13th SPORE Investigators' Workshop,Washington, DC,
July 9-12, 2005. 2005:150 Abstract #149.
Rigol N, Frank NY, Margaryan A, Schatton T, Frank MH. Differential expression
of ABCB5 multidrug resistance P-glycoprotein in human breast cancer cell
lines. Proceedings of the Department of Defense Breast Cancer Research
Program Meeting (Era of Hope), June 8-11, 2005, Philadelphia, PA. 2005:467
Abstract P66-7.
Schatton T, Yamaura K, Kupper TS, Sayegh MH, Murphy GF, Frank MH.
ABCB5: A Novel Molecular Marker For Melanoma Stem Cells? The Tony
& Shelly Malkin Stem Cell Symposium, Harvard Stem Cell Institute,
Boston, MA. 2005.
Schatton T, Murphy GF, Frank NY, Yamaura K, Zhan Q, Rigol N, Margaryan A,
Jordan S, Duncan LM, Kupper TS, Sayegh MH, Frank MH. The chemoresistance
mediator ABCB5 identifies melanoma stem cells. National Cancer Institute
14th SPORE Investigators' Workshop. 2006:Abstract 150, p. 92.
Schatten S, Yang J, Chandraker A, Sayegh MH, Frank MH. In vivo
immunomodulatory function of ABCB5+ dermal mesenchymal stem cells.
American Journal of Transplantation. 2006;Supplement(World Transplant
Congress):Abstract 351: pp. 185-186.